Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keytruda and BCG in high-risk superficial UUTTCC
NCT03345134Phase 2Not yet recruiting
- Start
- Nov 2017
- Primary completion
- Jan 2021
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in upper urinary tract urothelial carcinoma (UTUC). Planned start Nov 2017; status: not yet recruiting.
02
Drugs
03
Conditions
upper urinary tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT03345134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03345134.